Serum Lactate Dehydrogenase Is a Novel Predictor for the Severity in the Patients With MAFLD: A Cross-Sectional Study in Hefei, China
Increased LDH levels were significantly and independently associated with the presence and severity of metabolic syndrome and MAFLD, indicating that LDH could be used as a novel biomarker and clinical predictor of severity of metabolic syndrome and MAFLD.
Authors
- Feng Zhu (ORCID: https://orcid.org/0000-0002-8131-1219)
- Fuqiang Zu
- Wei Chen (ORCID: https://orcid.org/0000-0003-4153-9873)
- Song Chen (ORCID: https://orcid.org/0000-0001-6412-5740)
- Yanyan Xu (ORCID: https://orcid.org/0000-0001-5429-3177)
- Yanwei Liu (ORCID: https://orcid.org/0000-0002-4136-3954)
- Rong Jiang (ORCID: https://orcid.org/0009-0000-7642-932X)
- Liang Yu (ORCID: https://orcid.org/0000-0003-4547-8318)
- Shiming Bao
Institutions
- Anhui Medical University (CN)
- The People's Hospital Tongling (CN)
- Chuzhou University (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
- Second Affiliated Hospital of Anhui Medical University (CN)
Publication Details
- Journal
- Diabetes Metabolic Syndrome and Obesity
- Published
- 2025-02-01
- DOI
- https://doi.org/10.2147/dmso.s492153
- Citations
- 2
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.71
Funders
- Anhui Medical University